Abstract:Tripartite motif (TRIM) 59 protein, a cancer-associated E3 ubiquitin ligase, plays important roles in various biological processes including innate immune response, autophagy, cell cycle, glycolysis and tumorigenicity. The mechanism of autophagy regulated by TRIM59 in non-small cell lung cancer (NSCLC) has been elucidated clearly. It has been demonstrated that TRIM59 was a novel molecule prognostic factor of NSCLC and frequently up-regulated in NSCLC patients, that was verified in The Cancer Genome Atlas (TCGA) datasets. Nevertheless, it still remains unclear of the correlation between TRIM59 expression and immune infiltrates as well as the predictive value of TRIM59 in lung adenocarcinoma (LUAD). In this study, analysis of TRIM59 expression in normal and tumor tissues indicated that TRIM59 was up-regulated in most tumor tissues based on RNA-seq datasets from TCGA and Genotype-Tissue Expression (GTEx) databases. The correlation analysis between TRIM59 expression and overall survival (OS), disease-specifical survival (DSS), disease-free interval (DFI) or progress free interval (PFI), suggested that high TRIM59 expression predicted adverse outcomes in LUAD (OS: P=0.00096; DSS: P=0.00056; DFI: P=0.0009; PFI: P=0.0012). The correlation analysis between TRIM59 and immune checkpoints revealed that TRIM59 was significantly correlated with most of immune checkpoints in TCGA database, and TRIM59 had significant correlation with TMB (P<0001), ESITIMATE score (P=0.04) or stromal score (P=0.005) in LUAD. Further investigation demonstrated that the significantly negative correlation between TRIM59 expression and tumor purity was only shown in LUAD (P=0.027). It was found that TRIM59 had significant correlation with gene markers on macrophage and neutrophil in Tumor Immune Estimation Resource (TIMER) database, indicating that TRIM59 expression in LUAD played an essential regulatory role in tumor immune progress including infiltration of macrophage and neutrophil. Functional enrichment analysis as well as correlation analysis between TRIM59 and clinical characteristics of LUAD patients was also performed in our report. Combined with previously reported prognostic role of TRIM59 in NSCLC, our results proved that TRIM59 is a prognosticator for LUAD and is correlated with immune infiltrates in LUAD. Funding Statement: This work was supported by the National Natural Science Foundation of China (81703072), The Natural Science Foundation of Zhejiang Province (LQ21H160027). Declaration of Interests: The authors have no conflict of interests.

TRIM2 Downregulation in Clear Cell Renal Cell Carcinoma Affects Cell Proliferation, Migration, and Invasion and Predicts Poor Patients’ Survival

Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma

TRIM29 is Differentially Expressed in Colorectal Cancers of Different Primary Locations and Affects Survival by Regulating Tumor Immunity Based on Retrospective Study and Bioinformatics Analysis

Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study

Identification TRIM46 as a Potential Biomarker and Therapeutic Target for Clear Cell Renal Cell Carcinoma Through Comprehensive Bioinformatics Analyses

High TRIM59 Expression Predicts Adverse Outcomes and is Correlated with Immune Infiltrates in Lung Adenocarcinoma

TRIM2 is a novel promoter of human colorectal cancer

TRIM13 Inhibits Cell Migration and Invasion in Clear-Cell Renal Cell Carcinoma.

Correlation Between Tripartite Motif-Containing Protein 44 Protein Expression and the Prognosis of Postoperative Patients Exhibiting Skin Squamous Cell Carcinoma

Tripartite-motif Family Genes Associated with Cancer Stem Cells Affect Tumor Progression and Can Assist in the Clinical Prognosis of Kidney Renal Clear Cell Carcinoma.

Integrated Bioinformatics Analysis Reveals Correlations of High TRIM59 Expression with Worse Prognosis and Immune Infiltrates in Lung Adenocarcinoma

Tripartite Motif Containing 62 is a Novel Prognostic Marker and Suppresses Tumor Metastasis Via C-Jun/slug Signaling-Mediated Epithelial-Mesenchymal Transition in Cervical Cancer

TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma

TRIM27 is an adverse prognostic biomarker and associated with immune and molecular profiles in right-sided colon cancer

TRIM27 interacts with Iκbα to promote the growth of human renal cancer cells through regulating the NF-κB pathway

Silencing of the TRIM58 Gene by Aberrant Promoter Methylation is Associated with a Poor Patient Outcome and Promotes Cell Proliferation and Migration in Clear Cell Renal Cell Carcinoma

TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner

The Mechanism of TRIM21 Inhibiting the Invasion and Migration of ccRCC by Stabilizing ASS1

Decreased Expression of CTR2 Predicts Poor Prognosis of Patients with Clear Cell Renal Cell Carcinoma.

TRIM29 Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Activating Wnt/β-catenin Pathway in Cervical Cancer.

TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling